Dr. Massimo Cristofanilli
Admissions Committee

Massimo Cristofanilli, MD, FACP
Professor of Medicine

Robert Lurie Cancer Center, Northwestern University

Dr. Cristofanilli reciveived his medical degree in 1986 from the University “La Sapienza” Medical School in Rome (Italy) where he subsequently completed a Fellowship in Medical Oncology in November 1990. In July 1996, he started a Medical Oncology Fellowship at the University of Texas M. D. Anderson Cancer Center.
Dr Christian Rolfo
Educational Committee

Prof. Dr. Christian Rolfo, MD, PhD, MBA

He was born in Córdoba, Argentina in 1972; studied at the National University of Córdoba, graduating from the medical school in 1996. In 1998 he began his studies at the University of Milan, Italy.
Prof. Dr. María José Serrano
Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica | GENYO · ONCOLOGICAL RESEARCH. CTC GROUP
Dr. Juan José Díaz Mochón
Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica | GENYO · NanochemBio
Dr. Luis Paz-Ares
Hospital Universitario 12 de Octubre, Madrid, Spain

Media Relations Committee

Luis Paz-Ares is currently Chair of the Medical Oncology Department at the Hospital Doce de Octubre, Associate
Professor at the Universidad Complutense, and Head of the Lung Cancer Unit at the CNIO (National Oncology
Research Center), all in Madrid, Spain.
Dr. José Luis Costa
Clinical Implementation Committee

He is the Scientific Coordinator of the Genomics Core Facility and Principal Investigator at the newly established i3S - Instituto de Investigação e Inovação em Saúde. His career has focused on understanding the crucial genetic events that are the basis for the development and progression of cancer. To develop his work, he uses diverse genomic techniques, ranging from basic molecular biology tools to high-throughput technologies.
Prof. Joaquin Dopazo
Computational Committee

Director of the Bioinformatics Area, Fundacion Progreso y Salud, Sevilla, Spain

Clinical Bioinformatics Area, Fundacion Progreso y Salud,

CDCA, Hospital Virgen del Rocío, C/Manuel Siurot s/n.

Seville, Spain
Prof. Jesus Garcia-Foncillas MD PhD
Audit Committee

University Cancer Institute “OncoHealth”
University Hospital “Fundacion Jimenez Diaz”
Autonomous University of Madrid, Spain
Dr. Ignacio Gil-Bazo
Liquid Biopsy Samples Repository Committee

Chairman of Oncology Department
Codirector of the Lung Cancer Program
Associate Professor of Oncology (School of Medicine, University of Navarra)
Principal investigator at the Center for Applied Medical Research (CIMA)
Dr. Ignacio Duran
Publications Committee

Ignacio Durán, MD, PhD
Hospital Universitario ‘Virgen del Rocio’
Seville, Spain

Dr Durán is a member of the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Spanish Society of Medical Oncology. His major research interests include genitourinary tumours and anticancer clinical drug development. He has authored numerous publications covering diverse areas of medical oncology in peer-reviewed scientific journals.
Dr. Eduardo Díaz-Rubio
Grants And Prizes Committee

Eduardo Díaz-Rubio
Catedrático y Jefe Servicio Oncología Médica
Académico de Número de la Real Academia Nacional de Medicina
Hospital Universitario Clínico San Carlos
Facultad de Medicina, Universidad Complutense, Madrid.
Dr. Umberto Malapelle
Chair of Young Investigators

Assistant Professor in Anatomic Pathology in School of Medicine.
Department of Public Health, University Federico II of Naples
Dr. Clotilde Costa Nogueira
Dr Elke Smits
University of Antwerpen
Dr Evi Lianidou
Professor of Analytical Chemistry – Clinical Chemistry
Dr. Evi Lianidou is Professor of Analytical Chemistry and Clinical Chemistry at the Department of Chemistry, University of Athens, Greece. Dr Lianidou has established a Molecular Diagnostics Laboratory focused on Liquid Biopsy at the Department of Chemistry since 1998
Dr Raghu Kalluri
Professor and Chairman, Department of Cancer Biology
University of Texas MD Anderson Cancer Center. USA
Dr David Gandara
University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA

David R. Gandara, MD is a Professor of Medicine at the University of California at Davis (UCD) School of Medicine, is the Senior Advisor to the Director, and Director of the Thoracic Oncology Program at UC Davis Comprehensive Cancer Center (UCDCCC). He is a diplomat of the American Board of Internal Medicine specializing in Medical Oncology.
Dr Eloisa Jantus
Fundación Hospital General Universitario de Valencia · Molecular Oncology, Spain
Dr Ignacio Gil Bazo
MD Anderson, Spain
Dr Bernardino Alcázar Navarrete
Licenciado en Medicina y Cirugía. Universidad de Granada y Especialista en Neumología (Hospital Universitario Virgen de las Nieves de Granada). Actualmente es Facultativo Especialista de Neumología en el Hospital de Alta Resolución de Loja (Granada).

Su investigación clínica se centra en EPOC y asma bronquial, en la identificación de biomarcadores de respuesta al tratamiento inhalado en la EPOC, así como patrones de aparición de exacerbaciones frecuentes y consumo de recursos sanitarios.
Dr Leticia De Mattos Arruda
Dr Leticia De Mattos-Arruda, MD, PhD is a physician scientist medical oncologist at the Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. She worked at the VHIO conducting clinical trials and translational research projects from 2009 to 2014. In 2010, she was a recipient of the European Society for Medical Oncology (ESMO) Translational Research Fellowship and attended the 12o ECCO - AACR - EORTC - ESMO Workshop on Methods in Clinical Cancer Research.
Dr Clara Mayo de las Casas
Medical Oncologists
Pangaea Oncology
Barcelona, Spain
Dr Filip Janku
Department of Investigational Cancer Therapeutics, Division of Cancer Medicine
MD Anderson
Dr Raghu Kalluri
MD Anderson
Professor and Chairman, Department of Cancer Biology
University of Texas MD Anderson Cancer Center
*Adjunct Professor of Molecular and Cellular Biology
Baylor College of Medicine
*Adjunct Professor of Bioengineering
Rice University
Dr Simona Fontana
Università degli Studi di Palermo, Palermo
Dr. Manish Kohli
Huntsman Cancer Institute- University of Utah, USA.
The research of Manish Kohli, M.D., is focused on identifying biomarkers with predictive and prognostic impact in patients with advanced prostate cancer, advanced kidney cancer, advanced bladder cancer and all stages of testicular cancer.

In the Division of Medical Oncology at Mayo Clinic, Dr. Kohli also conducts and oversees phase I, II and III clinical trials in the advanced stages of these malignancies.
Dr Valerie Fraser
Cancer Research, Education and Public Policy Advocate
Director of Research and Advocacy
Inflammatory Breast Cancer International Consortium (ibcic.org)
Valerie serves as Officer and Director of Research and Advocacy for the Inflammatory
Breast Cancer International Consortium (ibcic.org). As a cancer research advocate she
has served on clinical trial working groups, scientific review panels, agent selection
committees, steering committees and advisory groups and as an advocate consultant
and peer
Dr Jean-Yves Pierga
Institut Curie, France
Dr. Rita Zamarchi
Istituto Oncologico Veneto
Dr. Alain .R. Thierry
Université de Sciencies Montpellier, France
Dr Clara Montagut
Parc de Salut Mar
Barcelona, Spain
Dr Natalia Malara
University Magna Graecia
Dr. Todd E. Druley
Todd E. Druley, MD, PhD is the Chief Medical Officer for ArcherDX, Inc. He is also an Associate Professor of Pediatrics, Genetics and Developmental Biology at Washington University School of Medicine in St. Louis. His work focuses on improved molecular diagnostics for precision cancer therapy as well as pediatric cancer predisposition.
Dr. Jose Luis García Giménez
El Dr. García Giménez se licenció en Ciencias Químicas en 2002 y dos años después obtuvo su licenciatura en Bioquímica por la Universitat de València. En el año 2007 finalizó su tesis doctoral en el Departamento de Química Inorgánica de la Facultat de Farmacia obteniendo el grado de doctor con sobresaliente “cum laude”.
es investigador post-doctoral del Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) e Investigador del Instituto de Investigación Sanitaria INCLIVA
Dr. Luca Quagliata
BloodPAC, USa
Dr. Matteo Allegretti
Oncogenomic and Epigenetic Unit

Department of Research, Advanced diagnostics and Technological innovation

IRCSS Regina Elena National Cancer Institute

Via E. Chianesi 53, 00144, Rome
Dr Bernd Giebel
University Hospital Essen
Dr Manu Carollo
Oxford Brookes University

graduated in 2015 with a 1st Class Honours with Distinction BSc/MSc in Chemistry and Pharmaceutical Technology at the University of Naples Federico II. I then undertook lab placements at Swansea, Newcastle and Cambridge Universities where I specialized in cancer biology and metastasis research. I then started to work in the Carter lab in 2017.
Lauren Leiman, MBA
Bloodpac USA
Dr Tim Forshew
Tim is both Head of Science and Innovation and co-founder of Inivata. He is also an honorary lecturer at UCL. Prior to Inivata, during his time at Cambridge University and Cancer Research UK, Tim was part of the team that first published detecting solid tumour mutations through next generation sequencing of cell free DNA. As a postdoctoral Researcher he won the 2009 Jeremy Jass Prize for his role in identifying fusion genes in Pilocytic Astrocytoma.
Show More

© 2019 by ISLB.